We are a global network of specialists working together to conquer lung and thoracic cancers worldwide.

GAIN: EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment, and Treatment

Multidisciplinary Live Learning:
Molecular Testing and Personalized Therapy in Lung Cancer

Visit the New IASLC Nurses & Allied Health Professionals Resource Center.


WCLC 2015 registration fees reduced.
Register now.

Featured Science and Communiqués

IASLC Board of Directors Election Results

IASLC's 2015 Board of Director election results are final. Please see the results in our July Newsletter.

World No Tobacco Day - May 31, 2015 - Stop illicit trade of tobacco products.

One in every 10 cigarettes, and many other tobacco products, consumed worldwide are illegal, making the illicit trade of tobacco products a major global concern from many perspectives, including health, legal, economic, governance and corruption.

Driver of non-small cell lung cancer, FGFR1, also in 23 percent of small cell lung cancer

The study identifies a subset of patients with small cell lung cancer with potentially over activated FGFR1 pathways as evidenced by FGFR1 gene amplification, increased FGFR1 mRNA levels, and high protein expression.

World experts gather for refocusing on patients with small cell lung cancer

Small cell lung cancer (SCLC) will be the concentrated focus when 100 global experts in the field meet for a workshop hosted by the International Association for the Study of Lung Cancer (IASLC) on April 22-24, 2015 at Memorial Sloan Kettering Cancer Center in New York City.